Can You Have a Healthy Pregnancy with Behçet's Disease?
At a Glance
Yes, women with Behçet's disease can have safe, healthy pregnancies and normal fertility. The key to success is planning ahead with your doctor to ensure your condition is stable and your medications are pregnancy-safe before trying to conceive.
In this answer
5 sections
Yes, women with Behçet’s disease can have safe pregnancies and healthy babies, and the condition does not typically reduce a woman’s ability to get pregnant [1]. The key to a successful pregnancy is careful planning. Most specialists recommend discussing family planning with your doctor 3 to 6 months in advance so you can wait until your disease has been stable and in remission before trying to conceive [2][3]. By working closely with a rheumatologist and a Maternal-Fetal Medicine (MFM) specialist—an obstetrician who specializes in high-risk pregnancies—most women navigate pregnancy smoothly without major disease flare-ups [3][4].
Fertility and Behçet’s Disease
For most women with Behçet’s disease, fertility is completely normal [1]. Studies looking at ovarian reserve—the number and quality of eggs a woman has—show that women with Behçet’s have similar levels to healthy individuals [1][5].
However, previous treatments for severe Behçet’s disease can sometimes impact fertility. Specifically, an immunosuppressive drug called cyclophosphamide (often used for severe blood vessel or neurological complications) carries a known risk of reducing ovarian reserve or causing premature menopause [6][7]. If you have been treated with cyclophosphamide in the past, or if it is being considered for your treatment, discuss fertility preservation options with your care team before starting the medication [8].
How Pregnancy Affects Behçet’s Disease
Many women wonder if the hormonal and physical changes of pregnancy will trigger a flare-up. Fortunately, the majority of women with Behçet’s disease do not experience a worsening of their symptoms while pregnant [3].
Getting your disease under control before conception is the best way to keep it quiet during pregnancy [3][9]. A planned pregnancy during a period of remission significantly lowers the chances of active inflammation [9][10]. If you are in the minority of women who do experience a flare during pregnancy, your doctor has options to manage it safely. Flare-ups are typically treated by adjusting your current pregnancy-safe medications (like colchicine or biologics) or by using short courses of medications like steroids to quickly reduce inflammation without harming the baby [11][12].
Managing Medications
Do not stop taking your medications without speaking to your doctor, as stopping suddenly can trigger a dangerous flare. Many medications used to manage Behçet’s disease can be safely continued during pregnancy, while others must be stopped or switched well in advance due to the risk of severe birth defects (teratogenicity) [3]:
- Medications that MUST be stopped: Drugs such as methotrexate, mycophenolate mofetil, and thalidomide are strictly prohibited during pregnancy because they can cause severe birth defects [3]. You must work with your rheumatologist to stop these and switch to a safer alternative several months before you start trying to conceive.
- Colchicine: This is one of the most commonly prescribed medications for the mucocutaneous (mouth and genital sores) and joint symptoms of Behçet’s disease [13]. Colchicine is generally considered safe to continue throughout pregnancy and is routinely recommended to prevent flare-ups [13][14].
- Biologics: Certain anti-TNF therapies (like infliximab or adalimumab) are frequently used to maintain control of the disease during pregnancy, especially if you have a history of severe symptoms, and are considered safe options [7][15].
Your rheumatologist and obstetrician will weigh the risks of the medication against the risks of a disease flare-up to create a safe treatment plan.
Pregnancy Risks and Monitoring
Having Behçet’s disease classifies your pregnancy as “high-risk,” meaning you will need closer monitoring [2][4]. Active inflammation or blood vessel involvement can sometimes adversely affect the pregnancy [3].
- Obstetric Complications: Active inflammation, especially if it affects the placenta (placental vasculitis), can increase the risk of miscarriage, premature birth, and fetal growth restriction (a smaller-than-average baby) [16]. This is why achieving remission before pregnancy is so important.
- Vascular complications: Because Behçet’s disease can cause inflammation in the blood vessels (vasculopathy), doctors will monitor you closely for blood clots, especially in the period immediately after delivery [16][17]. Depending on your history, your doctor might prescribe blood thinners (such as heparin injections) to reduce this risk [16].
- Gestational diabetes: Women with Behçet’s disease have a slightly elevated risk of developing gestational diabetes [17].
- Neonatal Behçet’s: In extremely rare cases, babies born to mothers with Behçet’s disease may develop temporary oral sores in the first few days of life [18]. This is a temporary condition that goes away on its own without long-term consequences [18].
Labor, Delivery, and Breastfeeding
Because Behçet’s disease can cause severe genital ulcers, many patients are anxious about labor and delivery. If you have active, severe genital sores at the time of delivery, vaginal birth can be extremely painful, risk poor healing, or cause the sores to worsen [19].
Additionally, Behçet’s disease is characterized by a phenomenon called pathergy, where trauma to the skin triggers a new inflammatory sore [20]. Because a vaginal delivery can cause tissue trauma (such as natural tearing or an episiotomy), it could trigger new, painful ulcerations that complicate your recovery [20][19]. For these reasons, your obstetrician may recommend a scheduled Cesarean section (C-section) if you have active genital involvement or a high risk of pathergy [19].
After birth, many women with Behçet’s disease successfully breastfeed. Medications like colchicine and biologics (such as infliximab or adalimumab) transfer into breast milk in very low, safe amounts and are generally considered compatible with breastfeeding [21][22]. Always confirm your postpartum medication plan with your pediatrician and rheumatologist.
Common questions in this guide
Does Behçet's disease make it harder to get pregnant?
Will my Behçet's disease symptoms get worse during pregnancy?
Can I keep taking my Behçet's disease medications while pregnant?
Can I have a vaginal birth if I have Behçet's disease?
Is it safe to breastfeed while taking Behçet's disease medications?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Is my current medication regimen pregnancy-safe, and do I need a 'washout' period for any drugs before trying to conceive?
- 2.Do I need a referral to a Maternal-Fetal Medicine (MFM) specialist to help monitor my pregnancy?
- 3.How will we manage my disease if I experience a flare-up while pregnant?
- 4.How will my history of Behçet's disease affect my labor and delivery plan, especially regarding the risk of pathergy or genital ulcers?
- 5.Which of my medications can I safely continue while breastfeeding?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (22)
- 1
Ovarian reserve is preserved in Behçet's disease.
şahİn A, Karakuş S, Durmaz Y, et al.
International journal of rheumatic diseases 2017; (20(12)):2070-2076 doi:10.1111/1756-185X.12693.
PMID: 26179772 - 2
Behçet's syndrome: recent advances to aid diagnosis.
Akbaba TH, Ekici M, Çolpak Aİ, et al.
Clinical and experimental medicine 2023; (23(8)):4079-4090 doi:10.1007/s10238-023-01226-7.
PMID: 37897656 - 3
Behçet's Disease and Pregnancy: A Retrospective Case-control Study.
Barros T, Braga A, Marinho A, Braga J
The Yale journal of biology and medicine 2021; (94(4)):585-592.
PMID: 34970095 - 4
One year in review 2020: Behçet's syndrome.
Hatemi G, Seyahi E, Fresko I, et al.
Clinical and experimental rheumatology 2020; (38 Suppl 127(5)):3-10.
PMID: 33331271 - 5
Risk Factors Associated with Impaired Ovarian Reserve in Young Women of Reproductive Age with Crohn's Disease.
Zhao Y, Chen B, He Y, et al.
Intestinal research 2020; (18(2)):200-209 doi:10.5217/ir.2019.00103.
PMID: 32224833 - 6
Pulmonary Artery Aneurysm in Behcet Disease: Medical, Endovascular or Surgical Intervention.
Samreen I, Darji P, Genobaga S, et al.
Cureus 2023; (15(11)):e49368 doi:10.7759/cureus.49368.
PMID: 38146562 - 7
Infliximab versus Cyclophosphamide for Severe Behçet's Syndrome.
Saadoun D, Maalouf G, Vieira M, et al.
NEJM evidence 2024; (3(11)):EVIDoa2300354 doi:10.1056/EVIDoa2300354.
PMID: 39437137 - 8
Behçet's Disease: Pulmonary Aneurysm Resolution with Oral Therapy and HLA B72 Allele Association.
de Albuquerque Botura C, Bersani-Amado LE, Zacarias-Júnior AR, et al.
Clinical medicine & research 2018; (16(1-2)):37-40 doi:10.3121/cmr.2017.1386.
PMID: 29610118 - 9
Impact of disease activity on health related quality of life in patients with Behçet's disease: A cross-sectional study.
Gorial FI, Jabbar MA
Annals of medicine and surgery (2012) 2020; (54()):43-46 doi:10.1016/j.amsu.2020.03.010.
PMID: 32368339 - 10
Behçet's syndrome.
Emmi G, Bettiol A, Hatemi G, Prisco D
Lancet (London, England) 2024; (403(10431)):1093-1108 doi:10.1016/S0140-6736(23)02629-6.
PMID: 38402885 - 11
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases.
Atienza-Mateo B, Martín-Varillas JL, Calvo-Río V, et al.
Arthritis & rheumatology (Hoboken, N.J.) 2019; (71(12)):2081-2089 doi:10.1002/art.41026.
PMID: 31237427 - 12
Diagnosis of Behçet's disease: clinical characteristics, diagnostic criteria, and differential diagnoses.
Kiafar M, Faezi ST, Kasaeian A, et al.
BMC rheumatology 2021; (5(1)):2 doi:10.1186/s41927-020-00172-1.
PMID: 33446282 - 13
Clinical features of Behçet's disease patients with joint symptoms in Japan: A national multicenter study.
Tono T, Kikuchi H, Sawada T, et al.
Modern rheumatology 2022; (32(6)):1146-1152 doi:10.1093/mr/roab092.
PMID: 34850090 - 14
Safety of systemic treatments for Behçet's syndrome.
Lopalco G, Rigante D, Lopalco A, et al.
Expert opinion on drug safety 2020; (19(10)):1269-1301 doi:10.1080/14740338.2020.1817379.
PMID: 32883123 - 15
Behçet's Disease-related Budd-Chiari Syndrome Successfully Managed with anti-TNF Antibody: A Case Report and Review of the Literature.
Erul E, Uzun GS, Koksal D, et al.
European journal of case reports in internal medicine 2022; (9(8)):003515 doi:10.12890/2022_003515.
PMID: 36093305 - 16
Behçet's disease in pregnancy: a case report and literature review.
Li X, Huang X, Yu X
BMC pregnancy and childbirth 2025; (25(1)):69 doi:10.1186/s12884-024-07063-0.
PMID: 39856578 - 17
Adverse pregnancy outcomes in women with Behçet's disease: population-based registry linkage study in Taiwan.
Chan TM, Chiou MJ, Kuo CF
Clinical rheumatology 2021; (40(10)):4135-4142 doi:10.1007/s10067-021-05688-6.
PMID: 33834360 - 18
Neonatal Behçet's syndrome: a case report and literature review.
Lino Ferreira Ferraz SC, Rabiço-Costa D, Andrade A, et al.
Reumatismo 2026; (78(1)) doi:10.4081/reumatismo.2026.1902.
PMID: 41685535 - 19
Clinical characteristics of behçet's disease in palestine, a retrospective cohort study.
Daraghma A, Baidoun L, Nazzal S, et al.
BMC rheumatology 2025; (9(1)):93 doi:10.1186/s41927-025-00544-5.
PMID: 40702524 - 20
The Pathergy Test as a Diagnostic Tool.
Kutlubay Z, Tüzün Y, Wolf R
Skinmed 2017; (15(2)):97-104.
PMID: 28528602 - 21
Oral ulcerations after placement of orthodontic braces and skin pustules after laser hair removal: novel inducers of pathergy reactions in new-onset Behçet's disease.
van de Ree-Pellikaan C, Kiewiet-Kemper RM, Tchetverikov I, Westerweel PE
BMJ case reports 2016; (2016()).
PMID: 26951437 - 22
Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Behçet’s disease: results from a large real-world observational study
Suzuki Y, Hagiwara T, Kobayashi M, et al.
Intestinal research 2021; (19(3)):301-312 doi:10.5217/ir.2020.00013.
PMID: 32814420
This page provides general information about pregnancy and fertility with Behçet's disease. Always consult your rheumatologist and maternal-fetal medicine specialist for personalized advice regarding your medications and birth plan.
Get notified when new evidence is published on Behçet disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.